Alpha HPA Limited
Alpha HPA Limited (A4N.AX) Financial Performance & Income Statement Overview
Explore the financials of Alpha HPA Limited (A4N.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Alpha HPA Limited (A4N.AX) Income Statement & Financial Overview
Review Alpha HPA Limited A4N.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $71067.00 | $18796.00 | $25259.00 | $7553.00 |
| Cost of Revenue | $6.90M | $5.78M | $641882.00 | $877738.00 |
| Gross Profit | -$6.83M | -$5.76M | -$616623.00 | -$870185.00 |
| Gross Profit Ratio | -$96.11 | -$306.53 | -$24.41 | -$115.21 |
| R&D Expenses | $67303.00 | $62500.00 | $186903.00 | -$1.62M |
| SG&A Expenses | $13.007M | $9.95M | $11.87M | $8.93M |
| Operating Expenses | $13.07M | $11.58M | $12.06M | $7.31M |
| Total Costs & Expenses | $19.98M | $17.36M | $12.70M | $8.19M |
| Interest Income | $0.00 | $1.15M | $486555.00 | $377677.00 |
| Interest Expense | $0.00 | $244139.00 | $8060.00 | $39869.00 |
| Depreciation & Amortization | $1.59M | $1.10M | $614647.00 | $870063.00 |
| EBITDA | -$19.90M | -$15.72M | -$14.11M | -$10.29M |
| EBITDA Ratio | -$280.08 | -$836.22 | -$558.65 | -$967.76 |
| Operating Income | -$19.90M | -$17.34M | -$12.68M | -$8.18M |
| Operating Income Ratio | -$280.09 | -$922.61 | -$501.84 | -$1082.95 |
| Other Income/Expenses (Net) | $4.06M | $911629.00 | -$2.06M | $337808.00 |
| Income Before Tax | -$15.84M | -$16.43M | -$14.73M | -$11.20M |
| Income Before Tax Ratio | -$222.89 | -$874.11 | -$583.31 | -$1482.47 |
| Income Tax Expense | $0.00 | $10000.00 | -$6.19M | -$3.00 |
| Net Income | -$15.84M | -$16.44M | -$8.54M | -$11.20M |
| Net Income Ratio | -$222.89 | -$874.64 | -$338.15 | -$1482.47 |
| EPS | -$0.01 | -$0.02 | -$0.009 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.009 | -$0.01 |
| Weighted Avg Shares Outstanding | $1.13B | $1.01B | $933.80M | $857.81M |
| Weighted Avg Shares Outstanding (Diluted) | $1.13B | $1.01B | $933.80M | $857.81M |
The company's financials show resilient growth, with revenue advancing from $7553.00 in Q4 2023 to $71067.00 in Q2 2025. Gross profit remained healthy with margins at -9611% in Q2 2025 compared to -11521% in Q4 2023. Operating income hit -$19.90M last quarter, sustaining a consistent -28009% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$19.90M. Net income rose to -$15.84M, while earnings per share reached -$0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan